Tirzepatide is a dual-action peptide that targets both GIP and GLP-1 receptors. It's the compound behind Mounjaro and is considered the next generation of metabolic research. Many researchers find it more effective than semaglutide alone for body composition studies.
Product Details
98%+ purity, third-party tested
Certificate of Analysis (COA) included
Fulfilled from the USA
For laboratory research use only (RUO) — not for human consumption